Africa CDC in talks with Pfizer for COVID treatment pill

DAKAR, Senegal — (AP) — The director of Africa’s Centers for Disease Control said the organization is talking to Pfizer about bringing its COVID-19 treatment pill to the continent, which has just passed 10 million cases.

The discussions come as Dr. John Nkengasong urges government and citizens not to relent on vaccinations and preventive measures as various countries come down from waves of increased infections from the omicron variant.

“We are working hand in hand. … We are in close discussions with Pfizer to see what can be done to make the drugs available on the continent,” Nkengasong said Thursday in a press briefing.

He said he hopes the treatment would help stressed health systems on the continent and would be part of an approach in 2022 that includes scaling up vaccines and expanding testing to help deal with the pandemic.

At least 39 countries have reported the new variant and the average increase of cases in Africa is about 11 percent, he said.

He noted that vaccination rates are still not high enough, saying governments are struggling because there are such high numbers of people only getting vaccinated when there is a peak, which leads to a lot of hospitalizations and pressure on the systems that can be avoided.

“My advice to the population on the continent is go get vaccinated,” he said. “If the population is not ready to go get the vaccines the governments have worked so hard to bring to the continent, I see why countries would not have an option other than to impose vaccine mandates.”

The continent has received more than 660 million doses of vaccines, with only about 340 million doses administered.

Africa has now recorded more than 10.1 million cases of coronavirus with 232,363 deaths across more than 50 countries, according to the Africa CDC.

For all the latest World News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TheDailyCheck is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.